- Home
- VTS vs QURE Comparison
VTS vs QURE Comparison
Compare VTS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- QURE
- Stock Information
- Founded
- VTS 2014
- QURE 1998
- Country
- VTS United States
- QURE Netherlands
- Employees
- VTS N/A
- QURE N/A
- Industry
- VTS Oil & Gas Production
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- VTS Energy
- QURE Health Care
- Exchange
- VTS Nasdaq
- QURE Nasdaq
- Market Cap
- VTS 879.2M
- QURE 725.4M
- IPO Year
- VTS N/A
- QURE 2007
- Fundamental
- Price
- VTS $20.93
- QURE $14.47
- Analyst Decision
- VTS Strong Buy
- QURE Strong Buy
- Analyst Count
- VTS 4
- QURE 10
- Target Price
- VTS $30.25
- QURE $37.20
- AVG Volume (30 Days)
- VTS 316.8K
- QURE 2.1M
- Earning Date
- VTS 05-05-2025
- QURE 05-09-2025
- Dividend Yield
- VTS 10.75%
- QURE N/A
- EPS Growth
- VTS N/A
- QURE N/A
- EPS
- VTS 0.76
- QURE N/A
- Revenue
- VTS $225,502,000.00
- QURE $20,201,000.00
- Revenue This Year
- VTS $36.97
- QURE $60.54
- Revenue Next Year
- VTS $4.55
- QURE $183.28
- P/E Ratio
- VTS $27.57
- QURE N/A
- Revenue Growth
- VTS 4.90
- QURE 6.30
- 52 Week Low
- VTS $18.90
- QURE $3.73
- 52 Week High
- VTS $28.41
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- VTS 43.89
- QURE 53.75
- Support Level
- VTS $20.53
- QURE $14.81
- Resistance Level
- VTS $21.61
- QURE $16.20
- Average True Range (ATR)
- VTS 0.55
- QURE 0.94
- MACD
- VTS -0.04
- QURE 0.03
- Stochastic Oscillator
- VTS 17.02
- QURE 53.62
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.